<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Mycology, pathogenesis, and epidemiology of blastomycosis</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Mycology, pathogenesis, and epidemiology of blastomycosis</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Mycology, pathogenesis, and epidemiology of blastomycosis</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Robert W Bradsher, Jr, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Carol A Kauffman, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Milana Bogorodskaya, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Mar 17, 2022.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Blastomycosis is a systemic pyogranulomatous infection primarily involving the lungs, which can be asymptomatic or can manifest as acute or chronic pneumonia. Hematogenous dissemination frequently occurs; extrapulmonary disease of the skin, bones, and genitourinary system is common, but almost any organ can be infected. Infection arises after inhalation of the conidia of <em>Blastomyces dermatitidis</em> or <em>Blastomyces gilchristii</em>. </p><p><em>Blastomyces</em> is a member of the family Ajellomycetaceae and order Onygenales. Fungal nomenclature has been changing based on multilocus phylogenetic analyses and sequencing, and <em>Blastomyces helicus, Blastomyces parvus, Blastomyces silverae</em>, and <em>Blastomyces percursus</em> have been placed in the genus <em>Blastomyces</em> rather than the genus <em>Emmonsia</em> [<a href="#rid1">1,2</a>]. <em>B. helicus</em> has been<em> </em>associated with disease in a small number of humans and domestic animals [<a href="#rid3">3</a>].</p><p>The basic mycology, pathogenesis, and epidemiology of blastomycosis will be reviewed here. The clinical manifestations and treatment of blastomycosis are discussed separately. (See  <a class="medical medical_review" href="/d/html/2437.html" rel="external">"Clinical manifestations and diagnosis of blastomycosis"</a> and  <a class="medical medical_review" href="/d/html/2463.html" rel="external">"Treatment of blastomycosis"</a>.)</p><p class="headingAnchor" id="H2"><span class="h1">MYCOLOGY</span><span class="headingEndMark"> — </span><em>Blastomyces</em> is a member of the family Ajellomycetaceae and order Onygenales. Phylogenetic analysis of 78 clinical and environmental isolates of <em>B. dermatitidis</em> from different geographic regions has revealed two distinct species of the fungus, <em>B. dermatitidis</em> and <em>B. gilchristii</em> [<a href="#rid4">4</a>]. In addition, fungal nomenclature has been changing based on multilocus phylogenetic analyses and sequencing, and <em>B. helicus, B. parvus, B. silverae</em>, and <em>B. percursus</em> have now been placed in the genus <em>Blastomyces</em> rather than the genus <em>Emmonsia</em> [<a href="#rid1">1,2</a>]. <em>B. helicus</em> has been<em> </em>associated with disease in a small number of humans and domestic animals [<a href="#rid3">3</a>]. (See <a class="local">'Epidemiology'</a> below.)</p><p class="bulletIndent1"><span class="glyph">●</span><strong><em>B. dermatitidis</em></strong><strong> and </strong><strong><em>B. gilchristii</em></strong> – The natural habitat of 169 strains of organisms collected from various geographic areas were examined with 25 microsatellite loci for phylogeographic analysis [<a href="#rid5">5</a>]. <em>B. gilchristii</em> strains were found only in isolates from Canada and some northern states in the US, while <em>B. dermatitidis</em> were from those same locations, plus along the Mississippi River drainage system and in southeastern states. Both were closely linked to freshwater drainage systems, and the diversity was speculated to have begun with receding glaciers covering much of North America in the Pleistocene epoch [<a href="#rid5">5</a>]. (See <a class="local">'Epidemiology'</a> below.)</p><p></p><p class="bulletIndent1"><em>B. dermatitidis</em> and <em>B. gilchristii</em> appear to cause similar clinical illness. Clinical laboratories do not differentiate between these two species and simply call them <em>B. dermatitidis.</em> Thus, the organism will be referred to as <em>B. dermatitidis</em> hereafter. </p><p></p><p class="bulletIndent1"><em>B. dermatitidis</em> refers to both the sexual and asexual stage of the organism. Previously, <em>Ajellomyces dermatitidis </em>was the name of the sexual stage of the organism, and <em>B. dermatitidis</em> was the name for the asexual state of the organism. Production of a sexual spore requires fusion of the nucleus of a positive type with a negative, the so-called heterothallic property; both mating types are equally capable of causing infection [<a href="#rid6">6</a>].</p><p></p><p class="bulletIndent1">Two serotypes of <em>B. dermatitidis</em> have been identified based upon the presence or absence of the A antigen. In a study of 102 isolates predominantly from North America, all of the North American isolates reacted with anti-A antibody, while 11 of 12 isolates from Africa failed to react [<a href="#rid7">7</a>]. Serologic differences in <em>B. dermatitidis</em> isolates from different geographic location in the United States and Africa have been detected using an enzyme-linked immunoassay, indicating that different genotypic groups exist [<a href="#rid8">8-10</a>]. The expression of clinical disease differs between African strains and others. One report of two different serotypes of <em>B. dermatitidis</em> from Africa showed serotype 2 strains lacked the coding sequence for the surface protein adhesin WI-1 in their genome, which may contribute to the observed differences in strain behavior [<a href="#rid11">11</a>].</p><p></p><p class="bulletIndent1"><em>B. dermatitidis</em> exhibits thermal dimorphism, growing as the mycelial phase at room temperature and as the yeast phase at 37ºC. Primary isolation is most dependable for the mycelial phase; colonies usually appear after one to three weeks of incubation at 30ºC. The mycelial colonies initially grow as a white mold that slowly turns light brown. The branching hyphae are 2 to 3 microns in diameter and have right angle conidiophores with a single round or oval terminal conidium. Early identification of mycelial cultures is possible using commercial test kits that identify fungal specific exoantigens or by chemiluminescent deoxyribonucleic acid (DNA) probes that recognize unique ribosomal ribonucleic acid (rRNA) sequences [<a href="#rid12">12,13</a>].</p><p></p><p class="bulletIndent1"><em>B. dermatitidis</em> changes into the yeast phase at 37°C. This dimorphism appears to result from a hybrid histidine kinase, which senses host signals and causes the mycelial to yeast shift of <em>B. dermatitidis</em> [<a href="#rid14">14</a>]. The wrinkled yeast colonies are cream or tan in color.</p><p></p><p class="bulletIndent1">Yeast cells, usually 8 to 15 microns in diameter, have a thick refractile cell wall  (<a class="graphic graphic_picture graphicRef62300" href="/d/graphic/62300.html" rel="external">picture 1</a>) and are multinucleate  (<a class="graphic graphic_picture graphicRef66379" href="/d/graphic/66379.html" rel="external">picture 2</a>). Reproduction is by a single broad-based bud  (<a class="graphic graphic_picture graphicRef63105" href="/d/graphic/63105.html" rel="external">picture 3</a>); the daughter cell is often as large as the mother cell before detachment.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong><em>B. helicus </em></strong>– <em>B. helicus</em>, which is morphologically distinct from <em>B. dermatitidis</em> and <em>B. gilchristii</em>,<em> </em>was formerly identified as <em>Emmonsia helicus. </em>The organisms are pleomorphic, variable-sized yeast cells that can have single or multiple buds, sometimes forming a chain [<a href="#rid3">3</a>]. The mycelial phase growth produces no conidia and has tightly coiled helical hyphae [<a href="#rid3">3</a>]. </p><p></p><p class="headingAnchor" id="H3"><span class="h1">PATHOGENESIS</span><span class="headingEndMark"> — </span>Blastomycosis infection begins with the inhalation of the conidia of <em>B. dermatitidis</em>. Following inhalation, conidia can undergo nonspecific phagocytosis and killing mediated by polymorphonuclear leukocytes (PMN), monocytes, and alveolar macrophages. In contrast, the yeast forms of the organism are more resistant to phagocytosis and killing. As an example, PMN can ingest conidia and kill approximately 50 percent, compared with 20 percent killing of yeast, which are too large for ingestion and are killed by PMN attachment and degranulation [<a href="#rid15">15</a>]. Conidia, the infectious stage, are converted to the yeast phase in tissue. This conversion results in a survival advantage and probably contributes to infection by <em>B. dermatitidis</em>.</p><p class="headingAnchor" id="H4"><span class="h2">Virulence factors</span><span class="headingEndMark"> — </span>Most dimorphic fungi grow as nonpathogenic molds in the environment and convert to pathogenic yeast in the host, suggesting that virulence factors are important for this phase change [<a href="#rid16">16</a>]. The cell wall of the yeast form of <em>B. dermatitidis</em> is the most well-studied virulence factor for the organism. The cell wall is quite thick, which contributes to its resistance to phagocytosis. The lipid and phospholipid content of the yeast cell wall have also been associated with virulence [<a href="#rid17">17,18</a>].</p><p>Conversion of <em>B. dermatitidis</em> to the yeast form induces the expression of an essential virulence factor, BAD-1 (formerly WI-1), a 120 kd glycoprotein adhesion and immune modulator of <em>B. dermatitidis</em> [<a href="#rid16">16,19</a>]. BAD-1 is expressed on the cell surface and is released into the extracellular matrix [<a href="#rid16">16,20</a>]. Yeast phase-specific gene expression of BAD-1 is transcriptionally regulated and its promoter shares homology with that of the yeast phase-specific gene of <em>Histoplasma capsulatum</em> [<a href="#rid21">21</a>]. BAD-1 functions as an adhesin that can bind to CR3 and CD14 of human macrophages [<a href="#rid22">22</a>]. It contains a cysteine-rich domain at its carboxy terminal end that is similar to epidermal growth factor (EGF) and may mediate binding to extracellular matrix [<a href="#rid23">23</a>]. The C terminal EGF-like domain is required for BAD-1 localization to yeast surfaces during cell wall biogenesis.</p><p>One group of investigators utilized a recombinant strain of <em>B. dermatitidis</em> that lacked BAD-1 (WI-1) and was not pathogenic in animals as a live-attenuated vaccine in mice; administration of the vaccine strain induced a cellular immune response by CD4+ and CD8+ type 1 (T1) cells and protected animals against lethal experimental pulmonary infection [<a href="#rid24">24,25</a>]. Although interleukin (IL)-12 was absolutely required for cellular immunity, a differential dependency was noted in that CD4+ T cells required IL-12 whereas CD8+ T cells were less dependent on this cytokine. However, once CD4+ and CD8+ T cells have acquired a protective T1 phenotype, the presence of IL-12 was not necessary for maintenance of protective memory [<a href="#rid24">24</a>].</p><p>The results of these studies indicate that developing a vaccine to prevent disease in humans is possible. Potential candidates for such a vaccine might include those at high risk of developing blastomycosis such as woodsmen, veterinarians, and immunocompromised hosts living in endemic areas. Although these animal studies are promising, this vaccine strain has not yet been tested in humans.</p><p class="headingAnchor" id="H406008341"><span class="h2">Genotype</span><span class="headingEndMark"> — </span>In one study, microsatellite genotyping was performed on 227 isolates of <em>B. dermatitidis</em> from Wisconsin collected over a 10-year period, and the genotype (group 1 or 2) was correlated to clinical phenotype [<a href="#rid26">26</a>]. On univariate analysis, genotype group 1 isolates were more likely to be associated with pulmonary-only infections and constitutional symptoms such as fever, whereas genotype group 2 isolates were more likely to be associated with disseminated disease, older age, and the presence of comorbidities. However, on multivariate analysis, only time from disease onset to diagnosis of &gt;1 month, older age, and cigarette smoking were found to be independently associated with group 2 genotype infections. It is possible that the associations observed on univariate analysis were not detected on multivariate analysis due to inadequate sample size. Additional research needs to be done to determine whether an association exists between genotype and clinical manifestations.</p><p class="headingAnchor" id="H5"><span class="h2">Host defense</span><span class="headingEndMark"> — </span>The major acquired host defense against <em>B. dermatitidis</em> is cellular immunity, which is mediated by antigen-specific T lymphocytes and lymphokine-activated macrophages. Subcutaneous injections of live or killed <em>B. dermatitidis</em> in mice induces cellular immunity [<a href="#rid27">27</a>], and resistance to infection parallels the development of the cellular immune response, including delayed-type hypersensitivity and proliferative responses in splenocytes and lymph node cells [<a href="#rid28">28,29</a>]. The development of antigen-induced lymphocyte proliferation has been documented clinically with a variety of <em>Blastomyces</em> antigens [<a href="#rid30">30-32</a>].</p><p>In contrast with cellular immunity, specific antibody against <em>B. dermatitidis</em> does not appear to confer resistance to or hasten recovery from clinical infection [<a href="#rid29">29</a>].</p><p class="headingAnchor" id="H6"><span class="h1">EPIDEMIOLOGY</span><span class="headingEndMark"> — </span>Our knowledge of the epidemiology of blastomycosis remains incomplete because of the lack of well-characterized antigens for skin testing or for seroepidemiologic studies. Current information on the epidemiology of blastomycosis is based upon clinical reports of sporadic cases in humans and dogs and the study of point source outbreaks of disease [<a href="#rid33">33</a>]. </p><p class="headingAnchor" id="H2810574010"><span class="h2">B. dermatitidis and B. gilchristii</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Geographic distribution</strong> – Most cases of blastomycosis have been reported in North America. Endemic areas include the southeastern and south-central states bordering the Mississippi and Ohio River basins, the midwestern states and Canadian provinces bordering the Great Lakes, and a small area in New York and Canada along the St. Lawrence River and the Nelson River. There have been more reports of sporadic blastomycosis in Ontario, Manitoba, New York, and Wisconsin in recent years [<a href="#rid34">34-36</a>]. Outside of North America, blastomycosis has been reported most frequently in Africa, with occasional cases identified in Mexico, Central and South America, India, and the Middle East.</p><p></p><p class="bulletIndent1">Phylogenetic analysis of 78 clinical and environmental isolates of <em>B. dermatitidis</em> from different geographic regions has revealed two distinct species of the fungus, <em>B. dermatitidis</em> and <em>B. gilchristii</em> [<a href="#rid4">4</a>]. <em>B. gilchristii</em> was isolated from two North American locations known to be hyperendemic for blastomycosis: the Kenora region of Ontario and the Eagle River region of Wisconsin. There is speculation as to whether the high rates of infection in these areas might be due to <em>B. gilchristii</em> being a more pathogenic species or whether favorable environmental factors allowed emergence of this species. (See <a class="local">'Mycology'</a> above.) </p><p></p><p class="bulletIndent1">Outbreaks or epidemics of blastomycosis have been reported and have often been associated with waterways [<a href="#rid33">33,34</a>]. An outbreak of blastomycosis occurred in Indianapolis, Indiana, between 2005 and 2008; 34 cases were diagnosed during this time and coincided with major highway projects in the same region [<a href="#rid37">37</a>]. The peak incidence was 1.15 cases per 100,000 population in 2006, compared with 0.12 per 100,000 population in 2003.</p><p></p><p class="bulletIndent1">The ecology of blastomycosis has not been completely defined because of the difficulty in isolating the organism in nature. However, the environmental isolation <em>of B. dermatitidis</em> in association with two outbreaks of disease has been instrumental in clarifying the ecologic niche of the organism [<a href="#rid38">38,39</a>]. In both studie<em>s, Blastomyces </em>was isolated from soil containing decaying vegetation or from decomposed wood. The recent rainfall and the proximity to water noted in both outbreaks support the concept that humidity is important in promoting growth of the organism. A variety of wood by-products and animal waste substrates, in combination, support the growth <em>of B. dermatitidis </em>[<a href="#rid40">40</a>].</p><p></p><p class="bulletIndent1">Thus,<em> B. dermatitidis</em> probably grows as microfoci in the warm, moist soil of wooded areas rich in organic debris. The conditions that support growth of<em> Blastomyces</em> in these microfoci probably exist for only a short time. When a sporadic case or outbreak is identified, a possible explanation for the inability to isolate the organism in the environment is that the conditions promoting growth may no longer exist at the site of exposure.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Characteristics associated with infection </strong>– A large outbreak of 55 cases of blastomycosis occurred in Marathon County in North Central Wisconsin in 2009 and 2010 [<a href="#rid41">41</a>]. Among patients in the outbreak, 65 percent were male and 45 percent were of Hmong ethnicity, the predominant Asian group in the affected county. The overall incidence of blastomycosis increased significantly since 2005 (average 11 percent increase per year), and the incidence was significantly higher among Asian than non-Asian populations (2010 incidence: 168 versus 13 per 100,000 population). Since 2005, the incidence of blastomycosis increased more than 500 percent among the Hmong population in this region. When cases that were clustered in households and neighborhoods were compared with controls from the same households and neighborhoods that did not have blastomycosis, Hmong ethnicity and having a chronic medical condition were independently associated with development of blastomycosis. Exposures usually associated with increased risk for blastomycosis were not seen in the Asian cases. These observations raise the question as to whether there is a genetic predisposition leading to infection with <em>B. dermatitidis</em> among the Hmong.</p><p></p><p class="bulletIndent1">Despite early studies of endemic cases, which indicated that middle-aged men with outdoor occupations were at greatest risk for blastomycosis, review of most reported outbreaks indicates no sex, age, occupation, or seasonal predilection for blastomycosis. Exposure to soil, whether related to work or recreation, appears to be the common factor associated with both endemic and epidemic disease.</p><p></p><p class="bulletIndent1">A review was performed using the State Inpatient Database from the United States Agency for Healthcare Research and Quality (AHRQ) from 46 states [<a href="#rid42">42</a>]. Men accounted for 64 percent of cases, and the median age was 53. The incidence of hospitalization due to infection with this fungus was similar to previous reports from endemic areas in states within the Mississippi and Ohio River valleys. Illinois and Kentucky had the highest increase in incidence between 2001 and 2011, whereas Wisconsin had the highest age-adjusted hospitalization incidence of 2.9 hospitalizations per 100,000 patient-years.</p><p></p><p class="bulletIndent1">Not all patients diagnosed with blastomycosis are hospitalized, although reported hospitalization rates range from 57 to 70 percent [<a href="#rid35">35,41,42</a>]. However, these numbers are thought to be falsely elevated due to detection of the more severe cases by surveillance programs. </p><p></p><p class="bulletIndent1">An analysis of 477 patients from one health system revealed racial differences in hospitalization from blastomycosis, with a greater frequency, despite a younger age, in Asian, African American, and American Indian or Alaska Native populations compared with non-Hispanic White persons. Non-Hispanic White individuals were more likely to have had <em>B. dermatitidis</em> isolated than the other groups, who were more likely to have had isolation of <em>B. gilchristii </em>[<a href="#rid43">43</a>].</p><p></p><p class="headingAnchor" id="H2345888668"><span class="h2">B. helicus</span><span class="headingEndMark"> — </span><em>B. helicus</em> has been reported in a small number of infections in humans and domestic animals in western Canada and western United States [<a href="#rid3">3</a>]. Six of the seven humans with available clinical data had immunocompromising conditions, including human immunodeficiency virus (HIV)/ acquired immunodeficiency syndrome (AIDS), liver transplantation, lupus erythematosus, chronic leukemia with use of corticosteroids, and diabetes mellitus with concurrent alcoholism [<a href="#rid3">3</a>]. Blood cultures and cerebrospinal fluid and bronchoalveolar fluid cultures yielded the organism. Only two of the seven patients survived.</p><p class="headingAnchor" id="H376964238"><span class="h1">SUMMARY</span></p><p class="bulletIndent1"><span class="glyph">●</span>Blastomycosis is a systemic pyogranulomatous infection primarily involving the lungs, which can be asymptomatic or can manifest as acute or chronic pneumonia. Hematogenous dissemination frequently occurs; extrapulmonary disease of the skin, bones, and genitourinary system is common, but almost any organ can be infected. (See <a class="local">'Introduction'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Phylogenetic analysis has revealed two distinct species of the fungus, <em>Blastomyces dermatitidis</em> and <em>Blastomyces gilchristii</em>. Clinically, the organisms appear to cause similar clinical illness, are not differentiated by clinical laboratories, and will be referred to as <em>B. dermatitidis</em> hereafter. In addition, fungal nomenclature has been changing based on multilocus phylogenetic analyses and sequencing, and <em>Blastomyces helicus, Blastomyces parvus, Blastomyces silverae</em>, and <em>Blastomyces percursus</em> have now been placed in the genus <em>Blastomyces</em> rather than the genus <em>Emmonsia</em>. <em>B. helicus</em> has been<em> </em>associated with disease in a small number of humans and domestic animals. (See <a class="local">'Mycology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><em>Blastomyces</em> exhibits thermal dimorphism, growing as the mycelial phase at room temperature and as the yeast phase at 37°C. Yeast cells, usually 8 to 15 microns in diameter, have a thick refractile cell wall  (<a class="graphic graphic_picture graphicRef62300" href="/d/graphic/62300.html" rel="external">picture 1</a>) and are multinucleate  (<a class="graphic graphic_picture graphicRef66379" href="/d/graphic/66379.html" rel="external">picture 2</a>). Reproduction is by a single broad-based bud  (<a class="graphic graphic_picture graphicRef63105" href="/d/graphic/63105.html" rel="external">picture 3</a>); the daughter cell is often as large as the mother cell before detachment. (See <a class="local">'Mycology'</a> above.) </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Following inhalation, conidia can undergo nonspecific phagocytosis and killing mediated by polymorphonuclear leukocytes (PMN), monocytes, and alveolar macrophages. In contrast, the yeast forms of the organism are more resistant to phagocytosis and killing. As an example, PMN can ingest conidia and kill approximately 50 percent compared with 20 percent killing of yeast, which are too large for ingestion and are killed by PMN attachment and degranulation. (See <a class="local">'Pathogenesis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Most dimorphic fungi grow as nonpathogenic molds in the environment and convert to pathogenic yeast in the host, suggesting that virulence factors are important for this phase change. The cell wall of the yeast form of <em>B. dermatitidis</em> is the most well-studied virulence factor for the organism. The cell wall is quite thick, which contributes to its resistance to phagocytosis. The lipid and phospholipid content of the yeast cell wall have also been associated with virulence. (See <a class="local">'Virulence factors'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Conversion of <em>B. dermatitidis</em> to the yeast form induces the expression of an essential virulence factor, BAD-1 (formerly WI-1), a 120 kd glycoprotein adhesion and immune modulator of <em>B. dermatitidis</em>. (See <a class="local">'Virulence factors'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The major acquired host defense against <em>B. dermatitidis</em> is cellular immunity, which is mediated by antigen-specific T lymphocytes and lymphokine-activated macrophages. (See <a class="local">'Host defense'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Most cases of blastomycosis have been reported in North America. Endemic areas include the southeastern and south-central states bordering the Mississippi and Ohio River basins, the midwestern states and Canadian provinces bordering the Great Lakes, and a small area in New York and Canada along the St. Lawrence River. Outside of North America, blastomycosis has been reported most frequently in Africa with occasional cases identified in Mexico, Central and South America, India, and the Middle East. (See <a class="local">'B. dermatitidis and B. gilchristii'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Outbreaks or epidemics of blastomycosis have been reported and have often been associated with waterways. Exposure to soil, whether related to work or recreation, appears to be the common factor associated with both endemic and epidemic disease. (See <a class="local">'B. dermatitidis and B. gilchristii'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><em>B. helicus</em> has been isolated in the western United States and western Canada. In humans, disease has been seen primarily in patients with immunocompromising conditions. (See <a class="local">'B. helicus'</a> above.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Dukik K, Muñoz JF, Jiang Y, et al. Novel taxa of thermally dimorphic systemic pathogens in the Ajellomycetaceae (Onygenales). Mycoses 2017; 60:296.</a></li><li><a class="nounderline abstract_t">Jiang Y, Dukik K, Munoz J, et al. Phylogeny, ecology and taxonomy of systemic pathogens and their relatives in Ajellomycetaceae (Onygenales): Blastomyces, Emergomyces, Emmonsia, Emmonsiellopsis. Fungal Diversity 2018; 90:245.</a></li><li><a class="nounderline abstract_t">Schwartz IS, Wiederhold NP, Hanson KE, et al. Blastomyces helicus, a New Dimorphic Fungus Causing Fatal Pulmonary and Systemic Disease in Humans and Animals in Western Canada and the United States. Clin Infect Dis 2019; 68:188.</a></li><li><a class="nounderline abstract_t">Brown EM, McTaggart LR, Zhang SX, et al. Phylogenetic analysis reveals a cryptic species Blastomyces gilchristii, sp. nov. within the human pathogenic fungus Blastomyces dermatitidis. PLoS One 2013; 8:e59237.</a></li><li><a class="nounderline abstract_t">McTaggart LR, Brown EM, Richardson SE. Phylogeographic Analysis of Blastomyces dermatitidis and Blastomyces gilchristii Reveals an Association with North American Freshwater Drainage Basins. PLoS One 2016; 11:e0159396.</a></li><li><a class="nounderline abstract_t">McDonough ES, Lewis AL. Blastomyces dermatitidis: production of the sexual stage. Science 1967; 156:528.</a></li><li><a class="nounderline abstract_t">Kaufman L, Standard PG, Weeks RJ, Padhye AA. Detection of two Blastomyces dermatitidis serotypes by exoantigen analysis. J Clin Microbiol 1983; 18:110.</a></li><li><a class="nounderline abstract_t">Axtell RC, Scalarone GM. Serological differences in two Blastomyces dermatitidis isolates from different geographical regions of North America. Mycopathologia 2002; 153:141.</a></li><li><a class="nounderline abstract_t">Axtell RC, Scalarone GM. Serological differences in three Blastomyces dermatitidis strains. Mycoses 2002; 45:437.</a></li><li><a class="nounderline abstract_t">Abuodeh RO, Chester EM, Scalarone GM. Comparative serological evaluation of 10 Blastomyces dermatitidis yeast phase lysate antigens from different sources. Mycoses 2004; 47:143.</a></li><li><a class="nounderline abstract_t">Klein BS, Aizenstein BD, Hogan LH. African strains of Blastomyces dermatitidis that do not express surface adhesin WI-1. Infect Immun 1997; 65:1505.</a></li><li><a class="nounderline abstract_t">Kaufman L, Standard PG. Specific and rapid identification of medically important fungi by exoantigen detection. Annu Rev Microbiol 1987; 41:209.</a></li><li><a class="nounderline abstract_t">Stockman L, Clark KA, Hunt JM, Roberts GD. Evaluation of commercially available acridinium ester-labeled chemiluminescent DNA probes for culture identification of Blastomyces dermatitidis, Coccidioides immitis, Cryptococcus neoformans, and Histoplasma capsulatum. J Clin Microbiol 1993; 31:845.</a></li><li><a class="nounderline abstract_t">Nemecek JC, Wüthrich M, Klein BS. Global control of dimorphism and virulence in fungi. Science 2006; 312:583.</a></li><li><a class="nounderline abstract_t">Drutz DJ, Frey CL. Intracellular and extracellular defenses of human phagocytes against Blastomyces dermatitidis conidia and yeasts. J Lab Clin Med 1985; 105:737.</a></li><li><a class="nounderline abstract_t">Rooney PJ, Sullivan TD, Klein BS. Selective expression of the virulence factor BAD1 upon morphogenesis to the pathogenic yeast form of Blastomyces dermatitidis: evidence for transcriptional regulation by a conserved mechanism. Mol Microbiol 2001; 39:875.</a></li><li><a class="nounderline abstract_t">DISALVO AF, DENTON JF. LIPID CONTENT OF FOUR STRAINS OF BLASTOMYCES DERMATITIDIS OF DIFFERENT MOUSE VIRULENCE. J Bacteriol 1963; 85:927.</a></li><li><a class="nounderline abstract_t">Cox RA, Best GK. Cell wall composition of two strains of Blastomyces dermatitidis exhibiting differences in virulence for mice. Infect Immun 1972; 5:449.</a></li><li><a class="nounderline abstract_t">Brandhorst TT, Wüthrich M, Warner T, Klein B. Targeted gene disruption reveals an adhesin indispensable for pathogenicity of Blastomyces dermatitidis. J Exp Med 1999; 189:1207.</a></li><li><a class="nounderline abstract_t">Klein BS, Newman SL. Role of cell-surface molecules of Blastomyces dermatitidis in host-pathogen interactions. Trends Microbiol 1996; 4:246.</a></li><li><a class="nounderline abstract_t">Rooney PJ, Klein BS. Sequence elements necessary for transcriptional activation of BAD1 in the yeast phase of Blastomyces dermatitidis. Eukaryot Cell 2004; 3:785.</a></li><li><a class="nounderline abstract_t">Newman SL, Chaturvedi S, Klein BS. The WI-1 antigen of Blastomyces dermatitidis yeasts mediates binding to human macrophage CD11b/CD18 (CR3) and CD14. J Immunol 1995; 154:753.</a></li><li><a class="nounderline abstract_t">Hogan LH, Josvai S, Klein BS. Genomic cloning, characterization, and functional analysis of the major surface adhesin WI-1 on Blastomyces dermatitidis yeasts. J Biol Chem 1995; 270:30725.</a></li><li><a class="nounderline abstract_t">Wüthrich M, Warner T, Klein BS. IL-12 is required for induction but not maintenance of protective, memory responses to Blastomyces dermatitidis: implications for vaccine development in immune-deficient hosts. J Immunol 2005; 175:5288.</a></li><li><a class="nounderline abstract_t">Wüthrich M, Filutowicz HI, Klein BS. Mutation of the WI-1 gene yields an attenuated blastomyces dermatitidis strain that induces host resistance. J Clin Invest 2000; 106:1381.</a></li><li><a class="nounderline abstract_t">Meece JK, Anderson JL, Gruszka S, et al. Variation in clinical phenotype of human infection among genetic groups of Blastomyces dermatitidis. J Infect Dis 2013; 207:814.</a></li><li><a class="nounderline abstract_t">Cozad GC, Chang CT. Cell-mediated immunoprotection in blastomycosis. Infect Immun 1980; 28:398.</a></li><li><a class="nounderline abstract_t">Morozumi PA, Brummer E, Stevens DA. Protection against pulmonary blastomycosis: correlation with cellular and humoral immunity in mice after subcutaneous nonlethal infection. Infect Immun 1982; 37:670.</a></li><li><a class="nounderline abstract_t">Brummer E, Morozumi PA, Vo PT, Stevens DA. Protection against pulmonary blastomycosis: adoptive transfer with T lymphocytes, but not serum, from resistant mice. Cell Immunol 1982; 73:349.</a></li><li><a class="nounderline abstract_t">Klein BS, Sondel PM, Jones JM. WI-1, a novel 120-kilodalton surface protein on Blastomyces dermatitidis yeast cells, is a target antigen of cell-mediated immunity in human blastomycosis. Infect Immun 1992; 60:4291.</a></li><li><a class="nounderline abstract_t">Bradsher RW. Live Blastomyces dermatitidis yeast-induced responses of immune and nonimmune human mononuclear cells. Mycopathologia 1984; 87:159.</a></li><li><a class="nounderline abstract_t">Klein BS, Bradsher RW, Vergeront JM, Davis JP. Development of long-term specific cellular immunity after acute Blastomyces dermatitidis infection: assessments following a large point-source outbreak in Wisconsin. J Infect Dis 1990; 161:97.</a></li><li><a class="nounderline abstract_t">Klein BS, Vergeront JM, Davis JP. Epidemiologic aspects of blastomycosis, the enigmatic systemic mycosis. Semin Respir Infect 1986; 1:29.</a></li><li><a class="nounderline abstract_t">Saccente M, Woods GL. Clinical and laboratory update on blastomycosis. Clin Microbiol Rev 2010; 23:367.</a></li><li><a class="nounderline abstract_t">Benedict K, Gibbons-Burgener S, Kocharian A, et al. Blastomycosis Surveillance in 5 States, United States, 1987-2018. Emerg Infect Dis 2021; 27.</a></li><li><a class="nounderline abstract_t">Austin A, Tobin E, Judson MA, et al. Blastomycosis in the Capital District of New York State: A Newly Identified Emerging Endemic Area. Am J Med 2021; 134:e101.</a></li><li><a class="nounderline abstract_t">Carlos WG, Rose AS, Wheat LJ, et al. Blastomycosis in indiana: digging up more cases. Chest 2010; 138:1377.</a></li><li><a class="nounderline abstract_t">Klein BS, Vergeront JM, Weeks RJ, et al. Isolation of Blastomyces dermatitidis in soil associated with a large outbreak of blastomycosis in Wisconsin. N Engl J Med 1986; 314:529.</a></li><li><a class="nounderline abstract_t">Klein BS, Vergeront JM, DiSalvo AF, et al. Two outbreaks of blastomycosis along rivers in Wisconsin. Isolation of Blastomyces dermatitidis from riverbank soil and evidence of its transmission along waterways. Am Rev Respir Dis 1987; 136:1333.</a></li><li><a class="nounderline abstract_t">Baumgardner DJ, Laundre B. Studies on the molecular ecology of Blastomyces dermatitidis. Mycopathologia 2001; 152:51.</a></li><li><a class="nounderline abstract_t">Roy M, Benedict K, Deak E, et al. A large community outbreak of blastomycosis in Wisconsin with geographic and ethnic clustering. Clin Infect Dis 2013; 57:655.</a></li><li><a class="nounderline abstract_t">Seitz AE, Younes N, Steiner CA, Prevots DR. Incidence and trends of blastomycosis-associated hospitalizations in the United States. PLoS One 2014; 9:e105466.</a></li><li><a class="nounderline abstract_t">Anderson JL, Frost HM, King JP, Meece JK. Racial Differences in Clinical Phenotype and Hospitalization of Blastomycosis Patients. Open Forum Infect Dis 2019; 6:ofz438.</a></li></ol></div><div id="topicVersionRevision">Topic 2458 Version 29.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28176377" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Novel taxa of thermally dimorphic systemic pathogens in the Ajellomycetaceae (Onygenales).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Phylogeny, ecology and taxonomy of systemic pathogens and their relatives in Ajellomycetaceae (Onygenales): Blastomyces, Emergomyces, Emmonsia, Emmonsiellopsis</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29878145" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Blastomyces helicus, a New Dimorphic Fungus Causing Fatal Pulmonary and Systemic Disease in Humans and Animals in Western Canada and the United States.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23533607" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Phylogenetic analysis reveals a cryptic species Blastomyces gilchristii, sp. nov. within the human pathogenic fungus Blastomyces dermatitidis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27428521" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Phylogeographic Analysis of Blastomyces dermatitidis and Blastomyces gilchristii Reveals an Association with North American Freshwater Drainage Basins.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6021679" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Blastomyces dermatitidis: production of the sexual stage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6411760" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Detection of two Blastomyces dermatitidis serotypes by exoantigen analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11998876" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Serological differences in two Blastomyces dermatitidis isolates from different geographical regions of North America.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12472717" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Serological differences in three Blastomyces dermatitidis strains.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15078431" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Comparative serological evaluation of 10 Blastomyces dermatitidis yeast phase lysate antigens from different sources.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9119493" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : African strains of Blastomyces dermatitidis that do not express surface adhesin WI-1.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3318668" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Specific and rapid identification of medically important fungi by exoantigen detection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8463395" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Evaluation of commercially available acridinium ester-labeled chemiluminescent DNA probes for culture identification of Blastomyces dermatitidis, Coccidioides immitis, Cryptococcus neoformans, and Histoplasma capsulatum.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16645097" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Global control of dimorphism and virulence in fungi.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3998623" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Intracellular and extracellular defenses of human phagocytes against Blastomyces dermatitidis conidia and yeasts.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11251809" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Selective expression of the virulence factor BAD1 upon morphogenesis to the pathogenic yeast form of Blastomyces dermatitidis: evidence for transcriptional regulation by a conserved mechanism.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14044964" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : LIPID CONTENT OF FOUR STRAINS OF BLASTOMYCES DERMATITIDIS OF DIFFERENT MOUSE VIRULENCE.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4636784" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Cell wall composition of two strains of Blastomyces dermatitidis exhibiting differences in virulence for mice.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10209038" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Targeted gene disruption reveals an adhesin indispensable for pathogenicity of Blastomyces dermatitidis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8795162" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Role of cell-surface molecules of Blastomyces dermatitidis in host-pathogen interactions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15189999" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Sequence elements necessary for transcriptional activation of BAD1 in the yeast phase of Blastomyces dermatitidis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7529285" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : The WI-1 antigen of Blastomyces dermatitidis yeasts mediates binding to human macrophage CD11b/CD18 (CR3) and CD14.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8530512" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Genomic cloning, characterization, and functional analysis of the major surface adhesin WI-1 on Blastomyces dermatitidis yeasts.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16210634" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : IL-12 is required for induction but not maintenance of protective, memory responses to Blastomyces dermatitidis: implications for vaccine development in immune-deficient hosts.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11104791" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Mutation of the WI-1 gene yields an attenuated blastomyces dermatitidis strain that induces host resistance.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23230057" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Variation in clinical phenotype of human infection among genetic groups of Blastomyces dermatitidis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7399670" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Cell-mediated immunoprotection in blastomycosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7118253" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Protection against pulmonary blastomycosis: correlation with cellular and humoral immunity in mice after subcutaneous nonlethal infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6984364" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Protection against pulmonary blastomycosis: adoptive transfer with T lymphocytes, but not serum, from resistant mice.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1383148" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : WI-1, a novel 120-kilodalton surface protein on Blastomyces dermatitidis yeast cells, is a target antigen of cell-mediated immunity in human blastomycosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6513994" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Live Blastomyces dermatitidis yeast-induced responses of immune and nonimmune human mononuclear cells.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2295863" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Development of long-term specific cellular immunity after acute Blastomyces dermatitidis infection: assessments following a large point-source outbreak in Wisconsin.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3317597" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Epidemiologic aspects of blastomycosis, the enigmatic systemic mycosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20375357" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Clinical and laboratory update on blastomycosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33757624" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Blastomycosis Surveillance in 5 States, United States, 1987-2018.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33091391" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Blastomycosis in the Capital District of New York State: A Newly Identified Emerging Endemic Area.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20558552" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Blastomycosis in indiana: digging up more cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3945290" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Isolation of Blastomyces dermatitidis in soil associated with a large outbreak of blastomycosis in Wisconsin.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3688635" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Two outbreaks of blastomycosis along rivers in Wisconsin. Isolation of Blastomyces dermatitidis from riverbank soil and evidence of its transmission along waterways.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11761145" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Studies on the molecular ecology of Blastomyces dermatitidis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23735332" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : A large community outbreak of blastomycosis in Wisconsin with geographic and ethnic clustering.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25126839" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Incidence and trends of blastomycosis-associated hospitalizations in the United States.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31696142" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Racial Differences in Clinical Phenotype and Hospitalization of Blastomycosis Patients.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
